These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36297659)

  • 21. Bispecific aptamer-decorated and light-triggered nanoparticles targeting tumor and stromal cells in breast cancer derived organoids: implications for precision phototherapies.
    Camorani S; Caliendo A; Morrone E; Agnello L; Martini M; Cantile M; Cerrone M; Zannetti A; La Deda M; Fedele M; Ricciardi L; Cerchia L
    J Exp Clin Cancer Res; 2024 Mar; 43(1):92. PubMed ID: 38532439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon nanotubes (CNT)-loaded ginsenosides Rb3 suppresses the PD-1/PD-L1 pathway in triple-negative breast cancer.
    Luo X; Wang H; Ji D
    Aging (Albany NY); 2021 Jun; 13(13):17177-17189. PubMed ID: 34111025
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TGF-β1 and FOXM1 siRNA co-loaded nanoparticles by disulfide crosslinked PEG-PDMAEMA for the treatment of triple-negative breast cancer and its bone metastases in vitro.
    Wang X; Huang H; Xu W; Gong Y; Shi S; Wan X; Li P
    Drug Dev Ind Pharm; 2024 Sep; ():1-12. PubMed ID: 39286903
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of targeted therapy therapeutics to sensitize triple-negative breast cancer chemosensitivity utilizing bacteriophage phi29 derived packaging RNA.
    Zhang L; Mu C; Zhang T; Yang D; Wang C; Chen Q; Tang L; Fan L; Liu C; Shen J; Li H
    J Nanobiotechnology; 2021 Jan; 19(1):13. PubMed ID: 33413427
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted nanomedicine with anti-EGFR scFv for siRNA delivery into triple negative breast cancer cells.
    Nguyen PV; Hervé-Aubert K; David S; Lautram N; Passirani C; Chourpa I; Aubrey N; Allard-Vannier E
    Eur J Pharm Biopharm; 2020 Dec; 157():74-84. PubMed ID: 33059006
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor-targeted pH/redox dual-sensitive unimolecular nanoparticles for efficient siRNA delivery.
    Chen G; Wang Y; Xie R; Gong S
    J Control Release; 2017 Aug; 259():105-114. PubMed ID: 28159516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-delivery of EGFR and BRD4 siRNA by cell-penetrating peptides-modified redox-responsive complex in triple negative breast cancer cells.
    Zhang C; Yuan W; Wu Y; Wan X; Gong Y
    Life Sci; 2021 Feb; 266():118886. PubMed ID: 33310044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Folic acid-functionalized polyethylenimine superparamagnetic iron oxide nanoparticles as theranostic agents for magnetic resonance imaging and PD-L1 siRNA delivery for gastric cancer.
    Luo X; Peng X; Hou J; Wu S; Shen J; Wang L
    Int J Nanomedicine; 2017; 12():5331-5343. PubMed ID: 28794626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor targeting and therapeutic assessments of RNA nanoparticles carrying α9-nAChR aptamer and anti-miR-21 in triple-negative breast cancers.
    Liao YC; Cheng TC; Tu SH; Chang J; Guo P; Chen LC; Ho YS
    Mol Ther Nucleic Acids; 2023 Sep; 33():351-366. PubMed ID: 37547295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery.
    Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B
    Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting EGFR of triple-negative breast cancer enhances the therapeutic efficacy of paclitaxel- and cetuximab-conjugated nanodiamond nanocomposite.
    Liao WS; Ho Y; Lin YW; Naveen Raj E; Liu KK; Chen C; Zhou XZ; Lu KP; Chao JI
    Acta Biomater; 2019 Mar; 86():395-405. PubMed ID: 30660004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein.
    Chandra S; Michael Nguyen H; Wiltz K; Hall N; Chaudhry S; Olverson G; Mandal T; Dash S; Kundu A
    J Cancer Treatment Diagn; 2020; 4(1):1-13. PubMed ID: 32395707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A size-shrinkable matrix metallopeptidase-2-sensitive delivery nanosystem improves the penetration of human programmed death-ligand 1 siRNA into lung-tumor spheroids.
    Wen J; Qiu N; Zhu Z; Bai P; Hu M; Qi W; Liu Y; Wei A; Chen L
    Drug Deliv; 2021 Dec; 28(1):1055-1066. PubMed ID: 34078185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements.
    Hattab D; Bakhtiar A
    Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 33003468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cationic lipid-assisted nanoparticles for simultaneous delivery of CD47 siRNA and R848 to promote antitumor immune responses.
    Li S; Chen Y; Ma R; Du Y; Han B
    Front Pharmacol; 2023; 14():1142374. PubMed ID: 37063284
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeted immunotherapy of triple-negative breast cancer by aptamer-engineered NK cells.
    Chen Z; Zeng Z; Wan Q; Liu X; Qi J; Zu Y
    Biomaterials; 2022 Jan; 280():121259. PubMed ID: 34801254
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Establishing the promising role of novel combination of triple therapeutics delivery using polymeric nanoparticles for Triple negative breast cancer therapy.
    Misra R; Patra B; Varadharaj S; Verma RS
    Bioimpacts; 2021; 11(3):199-207. PubMed ID: 34336608
    [No Abstract]   [Full Text] [Related]  

  • 40. gH625 Cell-Penetrating Peptide Promotes the Endosomal Escape of Nanovectorized siRNA in a Triple-Negative Breast Cancer Cell Line.
    Ben Djemaa S; Hervé-Aubert K; Lajoie L; Falanga A; Galdiero S; Nedellec S; Soucé M; Munnier E; Chourpa I; David S; Allard-Vannier E
    Biomacromolecules; 2019 Aug; 20(8):3076-3086. PubMed ID: 31305991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.